Description
Drug Safety Evaluation, 4th Edition (PDF) – Pharmaceutical Development Series
Unlock the intricacies of drug safety with this comprehensive and meticulously designed guide that serves as an essential resource for professionals navigating the complex landscape of pharmaceuticals and therapeutics.
The Drug Safety Evaluation, Fourth Edition continues to fulfill its primary goal: to provide an extensive and practical framework for all stakeholders involved in the safety evaluation of drugs and biologics. This valuable text is aimed at healthcare providers, industry manufacturers, regulatory specialists, and researchers who strive to comprehend the rigorous processes that ensure the safety of medicinal products, ultimately paving the way for promising candidates to reach the marketplace.
Delving deep into specialized chapters, each section focuses on specific methods for evaluating potential hazards and addressing challenges encountered during drug development. It also sheds light on the scientific and philosophical underpinnings essential for tackling various safety concerns, including developmental toxicity and carcinogenicity, thereby equipping readers with knowledge and strategies to face emerging societal challenges and complexities.
With evolving regulatory frameworks, advancements in pharmaceutical development, and the profound impact of Covid-19 on research practices, this edition has undergone substantial revisions throughout its chapters, supplemented by four additional chapters that reflect current trends and issues.
Highlighted topics in this essential resource include:
- An updated appendix featuring a comprehensive guide to Contract Research Organizations (CROs) for study implementation
- Critical information sources pivotal for study and program design, as well as safety evaluations
- Detailed mechanisms and endpoints of drug toxicity, encompassing pilot toxicity testing and repeat dose safety assessments
- An overview of the drug development lifecycle within the global pharmaceutical landscape, including human safety regulations
- Insights into electronic recordkeeping, reporting procedures, hazard assessment processes, and formulation strategies
- An exploration of genotoxicity, QSAR tools for improving drug safety, toxicogenomics, non-rodent model studies, and testing for developmental and reproductive toxicity
Crafted specifically for professionals in the pharmaceutical and biotechnology sectors—including scientists, consultants, and academics—this text serves as a vital tool. It illustrates a scientifically sound yet pragmatic approach to overcoming the daily challenges of safety evaluation and problem-solving inherent in drug discovery and development.
978-1119755852
IMPORTANT: This purchase exclusively includes the ebook version of Drug Safety Evaluation, 4th Edition (Pharmaceutical Development Series) in PDF format. Please note, no access codes are provided.
Reviews
There are no reviews yet.